Munira Momin
Overview
Explore the profile of Munira Momin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mallya R, Naik B, Momin M
CNS Neurol Disord Drug Targets
. 2022 Jul;
22(7):950-972.
PMID: 35864791
Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder, which is characterised by a distinct clinical pattern of inattention, hyperactivity as well as impulsivity, which in turn interferes with the day-to-day...
12.
Jethva P, Momin M, Khan T, Omri A
Materials (Basel)
. 2022 Apr;
15(7).
PMID: 35407706
Upconverting luminescent nanoparticles (UCNPs) are "new generation fluorophores" with an evolving landscape of applications in diverse industries, especially life sciences and healthcare. The anti-Stokes emission accompanied by long luminescence lifetimes,...
13.
Nair A, Mallya R, Suvarna V, Khan T, Momin M, Omri A
Antibiotics (Basel)
. 2022 Jan;
11(1).
PMID: 35052985
Microbial pathogens are the most prevalent cause of chronic infections and fatalities around the world. Antimicrobial agents including antibiotics have been frequently utilized in the treatment of infections due to...
14.
Gupta B, Mishra V, Gharat S, Momin M, Omri A
Pharmaceuticals (Basel)
. 2021 Nov;
14(11).
PMID: 34832983
One of the major impediments to drug development is low aqueous solubility and thus poor bioavailability, which leads to insufficient clinical utility. Around 70-80% of drugs in the discovery pipeline...
15.
Adolfsen K, Callihan I, Monahan C, Greisen P, Spoonamore J, Momin M, et al.
Nat Commun
. 2021 Oct;
12(1):6215.
PMID: 34711827
In phenylketonuria (PKU) patients, a genetic defect in the enzyme phenylalanine hydroxylase (PAH) leads to elevated systemic phenylalanine (Phe), which can result in severe neurological impairment. As a treatment for...
16.
Momin M, Mishra V, Gharat S, Omri A
Expert Opin Drug Deliv
. 2021 Oct;
18(11):1741-1760.
PMID: 34605347
Introduction: Chronic wounds are a substantial burden on the healthcare system. Their treatment requires advanced dressings, which can provide a moist wound environment, prevent bacterial infiltration, and act as a...
17.
Amra K, Momin M, Desai N, Khan F
Int J Dermatol
. 2021 Jul;
61(4):484-507.
PMID: 34310695
The skin is the largest organ of the integumentary system with a multifunctional purpose to protect the body from heat and microbes, regulate body temperature, and act as a sensory...
18.
Shaikh M, Desai N, Momin M, Bhatt L
Curr Drug Deliv
. 2021 Jul;
18(10):1563-1573.
PMID: 34238183
Objective: The objective of this study was to develop and optimize a microflora-triggered colon targeted sustained-release dosage form using Gum Ghatti (GG) and Hydroxypropyl Methylcellulose (HPMC K100). Methods: GG and...
19.
Jain P, Kathuria H, Momin M
Pharmacol Ther
. 2021 Apr;
226:107871.
PMID: 33915179
Bladder cancer is the 10 most commonly occurring malignancy worldwide with a 75% of 5-year survival rate, while it ranks 13 among the deaths occurring due to cancer. The majority...
20.
Desai N, Momin M, Khan T, Gharat S, Ningthoujam R, Omri A
Expert Opin Drug Deliv
. 2021 Apr;
18(9):1261-1290.
PMID: 33793359
Introduction: The targeted delivery of anticancer agents to tumor is a major challenge because most of the drugs show off-target effect resulting in nonspecific cell death. Multifunctionalized metallic nanoparticles (NPs)...